Expertise in
6
conditions

Marc Hazzan

Lille, FR 
Expertise in
6
conditions
Lille, FR 

Overview

Marc Hazzan practices practicing medicine in Lille, France.

Mr. Hazzan is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, Interstitial Nephritis, Goodpasture Syndrome, Kidney Transplant, and Islet Cell Transplantation.

He is actively involved in clinical research, co-authoring 106 peer reviewed articles and participating in 6 clinical trials.

Gender

Male

Locations

Lille, France
Other Locations
Besancon, 25000, France
1, Rue De Germont, Rouen, 76031, France
Strasbourg, France
Amiens, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Multicenter, Two Arms, Randomized, Open Label Clinical Phase IV Study Investigating the Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection Within the First 6 Months Post-transplantation When Treated With an Immunosuppressive Regimen Including Everolimus (Certican®) and Reduced Dose of Cyclosporine A (Neoral®) Versus an Immunosuppressive Regimen With Mycophenolic Acid (Myfortic®) and Standard Dose of Cyclosporine A (Neoral®).
A Multicenter, Two Arms, Randomized, Open Label Clinical Phase IV Study Investigating the Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection Within the First 6 Months Post-transplantation When Treated With an Immunosuppressive Regimen Including Everolimus (Certican®) and Reduced Dose of Cyclosporine A (Neoral®) Versus an Immunosuppressive Regimen With Mycophenolic Acid (Myfortic®) and Standard Dose of Cyclosporine A (Neoral®).
Enrollment Status: Completed
Publish Date: July 27, 2026
Intervention Type: Drug
Study Phase: Phase 4
Identification of Key Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais, Normandy and Picardy Regions
Identification of Key Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais, Normandy and Picardy Regions
Enrollment Status: Completed
Publish Date: April 28, 2026
Evaluation of a Strategy Based on the 3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation: the I4BiS Study
Evaluation of a Strategy Based on the 3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation: the I4BiS Study
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Other, Drug
Study Drug: Corticosteroid boluses Methylprednisolone
Study Phase: Phase 3
Interest of Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure
Interest of Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure
Enrollment Status: Completed
Publish Date: November 21, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Impact of Therapeutic Hypothermia in Expanded Criteria Brain-dead Donors on Kidney-graft Function in the Kidney-transplant Recipients: Multicenter Randomized Controlled Trial HYPOREME
Impact of Therapeutic Hypothermia in Expanded Criteria Brain-dead Donors on Kidney-graft Function in the Kidney-transplant Recipients: Multicenter Randomized Controlled Trial HYPOREME
Enrollment Status: Completed
Publish Date: June 21, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
The Bacteriuria in Renal Transplantation (BiRT) Study: A Prospective, Randomized, Parallel-group, Multicenter, Open-label, Superiority Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria
The Bacteriuria in Renal Transplantation (BiRT) Study: A Prospective, Randomized, Parallel-group, Multicenter, Open-label, Superiority Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria
Enrollment Status: Completed
Publish Date: July 18, 2019
Intervention Type: Other
Study Phase: Phase 4
View 5 Less Clinical Trials

106 Total Publications

ECOSBot: a multicenter validation pilot study of a generative AI tool for OSCE-based nephrology training.
ECOSBot: a multicenter validation pilot study of a generative AI tool for OSCE-based nephrology training.
Journal: Clinical kidney journal
Published: July 03, 2025

Frequently Asked Questions about Marc Hazzan

Is Marc Hazzan a top-rated expert for Kidney Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Marc Hazzan is classified as an Elite expert for Kidney Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marc Hazzan participate in research or clinical trials?

Yes. Marc Hazzan has published 106 articles and abstracts on conditions like Kidney Transplant. You can view a list of Marc Hazzan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hazzan's expertise for a condition
ConditionClose
    View All 32 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile